AbbVie, Inc. (NYSE:ABBV) flagship product, Humira sales decelerated in the first three quarters of 2019 given the launch of... ByZacks Investment Research • Feb 04, 2020 AbbVie (ABBV ...

Monster Hunter Wilds is the big success story of February, according to Circana's charts, though overall industry sales are still in decline.

Fatalities from drugs including fentanyl are down from a 2022 peak.

Humira is starting to feel the effects of lower-cost biosimilar competition in some markets however, with sales falling for the first time in the second quarter of this year. The FDA approval for ...

By Keith Caulfield Lady Gaga’s MAYHEM moves in at No. 1 on the Billboard 200 albums chart, as the set debuts atop the tally dated March 22. It’s the seventh leader for the superstar.

The company has successfully navigated the challenging transition away from its former blockbuster Humira, demonstrating ... with combined sales increasing 51% and 50%, respectively, in 2024.

Bears worry about how the company will make up for income lost due to patent protection expiration of blockbusters such as Humira, though AbbVie does have some new drugs selling briskly.

RADIO AIRPLAY AUDIENCE IMPRESSIONS AS MEASURED BY LUMINATE AND SALES DATA AS COMPILED BY LUMINATE. Kendrick Lamar & SZA Last week Weeks at no. 1 Weeks on chart K.L.Duckworth, S.I.Rowe, A.Boggs ...

The company’s limited exposure to Medicare and Medicaid risks, following the sale of its Medicare business ... particularly with drugs like HUMIRA, is viewed as a potential catalyst for future ...

Analysts at William Blair pointed out that the use of povo might be largely restricted to patients who have not responded to other treatments, such as Humira and IL-17 biologics ... William Blair has ...

The company’s limited exposure to Medicare and Medicaid risks, following the sale of its Medicare business ... particularly with drugs like HUMIRA, is viewed as a potential catalyst for future growth.

Two biosimilars, to Humira® (adalimumab) and Stelara® (ustekinumab) are already approved and marketed in multiple global markets. The current development pipeline includes nine disclosed ...